Topical Hair Loss Treatments Market 2018

Improved Minoxidil Formulation Safe, Effective for Androgenetic Alopecia

Improved Minoxidil Formulation Safe, Effective for Androgenetic Alopecia

The results of the study demonstrated that DC0120 was noninferior to the comparator agent.

A new formulation of minoxidil (DC0120; Pierre-Fabre Dermatologie) with improved cosmetic characteristics is noninferior to a comparator minoxidil product (Alostil; Johnson & Johnson) for the stimulation of hair growth among men with androgenetic alopecia (AGA).

Results from the phase 2, multicenter, randomized, placebo-controlled, double-blind study conducted at 4 sites in Germany were published in the Journal of Cosmetic Dermatology.

In each of the participants, 2 10-cm2 areas on the scalp were randomly assigned to receive DC0120, the comparator agent, or 1 of 2 corresponding vehicles, with each applied 2 times daily for 16 weeks.

Measurements of nonvellus target area hair count (TAHC) within the treatment area were obtained at baseline and after 8 weeks and 16 weeks, by digital phototrichogram.

A total of 220 individuals with AGA were included in the analysis, with 210 completing the study. Overall, there were 110 patients in the DC0120 arm, 44 in the DC0120-comparator arm, 44 in the comparator-DC0120 vehicle arm, and 22 in the DC0120-vehicle comparator arm.

The mean age of the participants was 41.5±10.9 years (range, 19 to 62 years).

The results of the study demonstrated that DC0120 was noninferior to the comparator agent. Compared with the vehicle groups, both minoxidil treatments increased nonvellus TAHC at 8 weeks and 16 weeks. No new safety concerns were revealed.

The investigators concluded that DC0120 is as efficacious and safe as a similar marketed minoxidil agent for the stimulation of hair growth among men with AGA. They do indicate, however, that because the products used in this study were applied to small treatment areas rather than to the entire scalp, the study was not of sufficient size to determine less common adverse events.


Blume-Peytavi U, Issiakhem Z, Gautier S, et al. Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: a randomized, placebo-controlled, double-blind, noninferiority study [published online April 16, 2018]. J Cosmet Dermatol. doi: 10.1111/jocd.12541

Hair Loss Drug Minoxidil Might Improve Vascular Health

Topical Hair Loss Treatments Market 2018

Minoxidil Market Report 2017

United States Minoxidil Market Report 2017 : by applications, including Alopecia, Hair Loss Treatment, Hair Replacement Surgery and Chemotherapy, Forecast to 2022

Research N Reports has proclaimed the addition of a new market intelligence report, titled “United States Minoxidil Market Report 2017.” The report provides key statistics on the market status, present situation & future forecast of United States Minoxidil Market industry.

Minoxidil Market measure development will be driven by the general interest for balding treatment. Widening little veins and permitting hair regrowth by improving cell prosaisms are key elements for this item, an alluring hair regrowing pharmaceutical among men and ladies.

Riotous way of life, change in dietary patterns, rising feeling of anxiety and hormonal changes are capable elements for balding. United States alopecia (hair loss treatment) market was esteemed at more than USD XX billion of every 2016, which hopes to surpass USD XX billion income by 2022.

Endorsement from FDA to be sold the pharmaceutical without medicine over the counter for men and ladies makes the item more agreeable in the market.

Market Elements:

The United States Minoxidil market research report will assist you take well-versed decisions, understand opportunities, plan effective business strategies, plan new projects, analyze drivers and restraints and give you a vision on the industry forecast.

Report by material, application, and geography – United States prospect to 2022 is an expert and extensive research report on the United States major regional market conditions, focusing on the main regions (The West, Southwest, The Middle Atlantic, New England, The South and The Midwest).

This report focuses also on consumption, market share and growth rate of Minoxidil Market in each application, can be divided into various Applications.

The United States Minoxidil market applications/end users wise and product category wise examination. On the basis of end users / applications, this report focuses on the status and outlook for major applications/end users, sales volume, and market share and growth rate of the United States market for each application.

Significant Drivers and Limitations:

Key Players profiled in the “United States Minoxidil Market” Report include McNeil Consumer Healthcare, Changland Technology, Proderma SRL, Pharhome International, Metapharmaceutical, Suzhou Habourbiotech, Carnosine, Darkar Holdings, Loy Pharma Lab. It also provides essential information about leading companies, such as product specification, financial overview, business overview, contact information, and recent developments.

minoxidil market report

The challenges faced by the companies, the factors helping them to reach the top level in the United States Minoxidil market, and the strategies implemented by each of the market players to market their products have been given. With the help of such data, a stakeholder or an emerging player in the market is armed to make strategic decisions leading to their benefit or profit.

The research report profiles the players and offers a detailed report about the competitive landscape present in the United States Minoxidil market. Additionally, the report also includes overall analysis. The report also discusses the business and marketing strategies likely to be implemented by these in the coming few years.

Table of Contents:

Minoxidil Market Research 2017

  • Minoxidil Market Overview
  • Minoxidil Segment by Application, Type, Region
  • United States Minoxidil Market Competition by Manufacturers
  • United States Minoxidil Production, Revenue (Value) by Region (2012-2017)
  • United States Minoxidil Supply (Production), Consumption, Export, Import by Regions
  • United States Minoxidil Manufacturers Profiles/Analysis
  • Marketing Strategy Analysis, Distributors/Traders
  • Market Effect Factors Analysis
  • United States Minoxidil Market Forecast (2017-2022)
  • Research Findings and Conclusion

Purchase full report with Discount @

About Research N Reports:

Research N Reports spends significant time in industry analysis, advertise figures and therefore getting quality reports covering all verticals, regardless of whether be it gaining point of view on current economic situations or being ahead in the merciless Global competition.

Since we exceed expectations at business research to enable businesses to develop, we additionally offer consulting as an extended arm to our administrations which only causes us gain more insight into current trends and issues.